Dr. Ghisoli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7777 Forest Ln
Ste D400
Dallas, TX 75230Phone+1 972-566-6647Fax+1 972-234-2987
Education & Training
- University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009
- Driscoll Children's Hospital/Texas A&M College of MedicineResidency, Pediatrics, 2005 - 2006
- Central University of VenezuelaClass of 1998
Certifications & Licensure
- TX State Medical License 2009 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Gemogenovatucel-T (Vigil): bi-shRNA plasmid-based targeted immunotherapy.John Nemunaitis, Laura Stanbery, Adam Walter, Gladice Wallraven, Alexander Nemunaitis
Future Oncology. 2024-01-01 - 4 citationsPilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.Peter Anderson, Maurizio Ghisoli, Brian D Crompton, Kelly S Klega, Leonard H Wexler
Clinical Cancer Research. 2023-05-01 - 4 citationsMixed Phenotype Acute Leukemia, B/Myeloid (Bilineal and Biphenotypic), With t(2;22)(q35;q12);EWSR1-FEV.Crystal Montgomery-Goecker, Prasad Koduru, Giovanni A. Botten, Jian Xu, Maurizio Ghisoli
Journal of Pediatric Hematology/oncology. 2021-04-01
Press Mentions
- Cancer Vaccine Developed in North Texas Could Be ‘As Simple as A Flu Shot’June 13th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: